| Serial Number | 90252361 |
| Word Mark | P HLA PROTEIN |
| Filing Date | Tuesday, October 13, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 23, 2022 |
| Registration Number | 6828530 |
| Registration Date | Tuesday, August 23, 2022 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, September 7, 2021 |
| Description of Mark | The mark consists of a square on top with two squares on each side touching corners with one square on the bottom with the top left section missing and a floating square in the middle of the four squares forming the letter "P" next to the literal word "HLA Protein". |
| Goods and Services | Chemicals and biochemicals for in vitro clinical and medical use |
| Pseudo Mark | HUMAN LEUKOCYTE ANTIGEN |
| Goods and Services | Reagents for scientific, pharmaceutical, clinical, and medical research purposes; laboratory chemicals, namely, protein-based reagents used for the detection of antibodies and receptors in cell, blood, and tissue analysis for in vitro diagnostics for scientific use and research in the field of therapeutic reagent designs; chemicals and biochemicals in the nature of reactants and reagents for in vitro scientific or research use; chemicals and biochemicals for use in the manufacture of pharmaceutical preparations; chemical, biochemical and biotechnological solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with antibody and B or T cell detection, separation and labelling; biochemical reagents for detecting and analyzing molecules in protein arrays; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; chemical, biochemical and biotechnological products in the nature of reactants and reagents for use in biotechnological product development of therapeutics for the prevention and treatment of cancer, infectious diseases, autoimmune diseases and allergies; chemical, biochemical and biotechnological preparations used in industry and science, and in the development and manufacture of pharmaceuticals, pharmaceutical preparations and substances, for the prevention and treatment of cancer, infectious diseases, autoimmune diseases and allergies; chemical, biochemical and biotechnological preparations used in industry and science, and in the development and manufacture of pharmaceuticals, pharmaceutical preparations and substances, for the detection, prevention and treatment of rejection causing antibodies, B and T cells |
| Goods and Services | Medical consulting services for transplant and organ rejection assessment |
| Disclaimer with Predetermined Text | "HLA PROTEIN" |
| Goods and Services | Providing scientific, pharmaceutical, clinical, and medical research information via the internet; research and development of new products; pharmaceutical drug and biomarker preparation target discovery, development, and validation in the nature of research, development, and quality assurance services; pharmaceutical and scientific research and development services; medical research services; medical development services in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; clinical research services in the fields of pharmaceuticals, biology, chemistry, biochemistry, and clinical trials; clinical development services in the nature of scientific development of clinical trials; consulting services in the field of pharmaceutical assessment; scientific and medical research consulting services for transplant and organ rejection assessment; validation in the nature of quality assurance services, screening and mapping in the nature of scientific research and development of biological material for drug discovery and vaccine manufacturing purposes; providing scientific information and medical research information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; scientific and medical research and development in the field of cancer, infectious diseases, autoimmune diseases and allergies; scientific and medical research and development in the field of antibody, B cell and T cell detection in transplant and organ rejection |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, December 2, 2020 |
| Primary Code | 001 |
| First Use Anywhere Date | Monday, January 4, 2021 |
| First Use In Commerce Date | Monday, January 4, 2021 |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 14, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | Monday, January 4, 2021 |
| First Use In Commerce Date | Monday, January 4, 2021 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, December 2, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, December 21, 2020 |
| First Use In Commerce Date | Monday, December 21, 2020 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 14, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | Monday, December 21, 2020 |
| First Use In Commerce Date | Monday, December 21, 2020 |
| Party Name | Pure Protein L.L.C. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Austin, TX 78735 |
| Party Name | Pure Protein L.L.C. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Austin, TX 78735 |
| Party Name | Pure Protein L.L.C. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Austin, TX 78735 |
| Event Date | Event Description |
| Tuesday, August 23, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, August 23, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Saturday, July 16, 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Friday, July 15, 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Thursday, June 23, 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| Friday, June 3, 2022 | USE AMENDMENT FILED |
| Thursday, June 23, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Friday, June 3, 2022 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, May 3, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, April 29, 2022 | SOU EXTENSION 1 GRANTED |
| Friday, April 29, 2022 | SOU EXTENSION 1 FILED |
| Friday, April 29, 2022 | TEAS EXTENSION RECEIVED |
| Friday, February 25, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, November 2, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, September 7, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 7, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 18, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Sunday, August 1, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, May 14, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, May 14, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, May 14, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, March 29, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, March 29, 2021 | NON-FINAL ACTION E-MAILED |
| Monday, March 29, 2021 | NON-FINAL ACTION WRITTEN |
| Thursday, March 11, 2021 | ASSIGNED TO EXAMINER |
| Thursday, December 3, 2020 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, December 2, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, October 16, 2020 | NEW APPLICATION ENTERED |